BSE filing, NSE: CHPLIND. Summary written from the filing by ALFA Finder's alert engine.
Callista Industries Ltd: key numbers
- Share price
- ₹131.45
- Market cap
- ₹136.7 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.00 Cr
- P/E (TTM)
- -776.8×Sector 46.8×
- Promoter holding
- 11.27%-10.23% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Callista Industries Ltd
All →Callista Industries Convertible Warrants
Callista Industries allotted 8,30,000 shares on conversion of preferential warrants, receiving a Rs 62.25 lakh balance. Allottees include non-promoter Koriander Consultants LLP and promoter Ravi Jabbar Sharma.
- Value
- ₹0.62 Cr
Callista Industries Convertible Warrants
Callista Industries allotted 4,50,000 equity shares to Koriander Consultants LLP on conversion of warrants. The balance consideration of ₹33.75 lakh was received, lifting paid-up capital to ₹10.85 crore.
- Value
- ₹0.34 Cr
Callista Industries Convertible Warrants
Ravi Jabbar Sharma, part of the promoter group, acquired equity shares and warrants upon warrant conversion at Callista Industries Ltd. The transaction is valued at ₹0.3 Crore.
- Value
- ₹0.30 Cr
Callista Industries Convertible Warrants
Callista Industries Limited allotted 4,00,000 equity shares following the conversion of convertible warrants. This capital infusion of Rs 0.4 Crore strengthens the company's equity base.
- Value
- ₹0.40 Cr
Callista Industries Other Announcement
Callista Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of SEBI Listing Regulations.
Callista Industries Capital Structure Change
Callista Industries allotted 4,53,412 equity shares to Koriander Consultants LLP upon conversion of convertible warrants. The company received Rs.34.00 lakh (0.34 Crore) as the balance conversion consideration.
- Value
- ₹0.34 Cr
Other board meeting date announcements
All →B.D. Industries (Pune) Board Meeting Date
B. D. Industries (Pune) will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-year results. The agenda items are proposed only and no decision has been taken yet.
Health X Platform Board Meeting Date
Health X Platform will hold a board meeting on 14 November 2026 to approve quarterly results. Trading window stays closed until 48 hours after declaration.
Exato Technologies Board Meeting Date
Board meeting set for November 14, 2026 to approve half-year results and an ESOP scheme. Trading window closed from October 1.
Astal Laboratories Board Meeting Date
Astal Laboratories will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the meeting.
Brainbees Solutions Board Meeting Date
Brainbees Solutions will hold a board meeting on November 14, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 16.
Senco Gold Board Meeting Date
Senco Gold schedules a board meeting on 13 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after declaration.